Katie Ewer to Viral Vaccines
This is a "connection" page, showing publications Katie Ewer has written about Viral Vaccines.
Connection Strength
0.093
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 08 15; 396(10249):467-478.
Score: 0.047
-
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology. 2020 07; 160(3):223-232.
Score: 0.046